Stanley J.  Meresman net worth and biography

Stanley Meresman Biography and Net Worth

Director of Guardant Health
Stanley Meresman has served as a member of Guardant Health’s board of directors since May 2018. During the last ten years, Mr. Meresman has served on the boards of directors of various public and private companies, including service as chair of the audit committee for some of these companies. He currently serves on the board of directors, and as chair of the audit committee, of Snap, Inc. Previously, he served as a member of the board of directors, and chair of the audit committee, of Palo Alto Networks, Inc. from December 2014 to December 2018, LinkedIn Corporation from October 2010 to December 2016, Zynga Inc. from June 2011 to June 2015, Meru Networks, Inc. from September 2010 to May 2013, and Riverbed Technology, Inc. from March 2005 to May 2012. He also currently serves on the board, and as audit committee chair, of several private companies. From January 2004 to December 2004, Mr. Meresman was a Venture Partner with Technology Crossover Ventures, a private equity firm, and was General Partner and Chief Operating Officer of Technology Crossover Ventures from November 2001 to December 2003. During the four years before joining Technology Crossover Ventures, he was a private investor and board member and adviser to several technology companies. From May 1989 to May 1997, Mr. Meresman served as the Senior Vice President and Chief Financial Officer of Silicon Graphics, Inc. Mr. Meresman holds a B.S. degree in industrial engineering and operations research from the University of California, Berkeley and an M.B.A. degree from the Stanford Graduate School of Business.

What is Stanley J. Meresman's net worth?

The estimated net worth of Stanley J. Meresman is at least $61,713.95 as of May 24th, 2023. Mr. Meresman owns 3,557 shares of Guardant Health stock worth more than $61,714 as of April 26th. This net worth evaluation does not reflect any other investments that Mr. Meresman may own. Learn More about Stanley J. Meresman's net worth.

How do I contact Stanley J. Meresman?

The corporate mailing address for Mr. Meresman and other Guardant Health executives is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. Guardant Health can also be reached via phone at (855) 698-8887 and via email at [email protected]. Learn More on Stanley J. Meresman's contact information.

Has Stanley J. Meresman been buying or selling shares of Guardant Health?

Stanley J. Meresman has not been actively trading shares of Guardant Health in the last ninety days. Most recently, Stanley J. Meresman sold 4,934 shares of the business's stock in a transaction on Thursday, March 10th. The shares were sold at an average price of $58.74, for a transaction totalling $289,823.16. Learn More on Stanley J. Meresman's trading history.

Who are Guardant Health's active insiders?

Guardant Health's insider roster includes Derek Bertocci (CFO), Ian Clark (Director), Helmy Eltoukhy (CEO), Meghan Joyce (Director), Kumud Kalia (Insider), Samir Kaul (Director), Stanley Meresman (Director), Amelia Merrill (SVP), and Amirali Talasaz (COO). Learn More on Guardant Health's active insiders.

Are insiders buying or selling shares of Guardant Health?

During the last year, Guardant Health insiders bought shares 2 times. They purchased a total of 5,168 shares worth more than $136,480.85. During the last year, insiders at the sold shares 6 times. They sold a total of 10,991 shares worth more than $334,103.05. The most recent insider tranaction occured on March, 18th when insider Kumud Kalia bought 2,187 shares worth more than $38,972.34. Insiders at Guardant Health own 6.2% of the company. Learn More about insider trades at Guardant Health.

Information on this page was last updated on 3/18/2024.

Stanley J. Meresman Insider Trading History at Guardant Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/10/2022Sell4,934$58.74$289,823.16View SEC Filing Icon  
1/10/2022Sell4,934$86.08$424,718.72View SEC Filing Icon  
12/10/2021Sell4,934$95.59$471,641.06View SEC Filing Icon  
11/10/2021Sell4,934$106.38$524,878.92View SEC Filing Icon  
10/11/2021Sell4,934$103.59$511,113.06View SEC Filing Icon  
9/10/2021Sell4,934$129.78$640,334.52View SEC Filing Icon  
8/10/2021Sell4,934$114.31$564,005.548,993View SEC Filing Icon  
7/12/2021Sell4,934$124.27$613,148.188,993View SEC Filing Icon  
5/10/2021Sell4,934$133.01$656,271.348,993View SEC Filing Icon  
4/12/2021Sell4,934$153.74$758,553.168,993View SEC Filing Icon  
2/10/2021Sell4,934$162.71$802,811.148,993View SEC Filing Icon  
1/11/2021Sell4,934$142.00$700,628.008,993View SEC Filing Icon  
12/10/2020Sell4,954$125.44$621,429.769,013View SEC Filing Icon  
11/10/2020Sell5,000$110.30$551,500.009,059View SEC Filing Icon  
10/12/2020Sell5,000$109.37$546,850.009,059View SEC Filing Icon  
9/10/2020Sell5,000$94.22$471,100.009,059View SEC Filing Icon  
8/10/2020Sell5,000$87.00$435,000.009,059View SEC Filing Icon  
7/10/2020Sell6,000$86.66$519,960.0010,059View SEC Filing Icon  
6/10/2020Sell6,000$80.59$483,540.007,302View SEC Filing Icon  
5/11/2020Sell6,500$86.50$562,250.007,802View SEC Filing Icon  
4/13/2020Sell9,500$66.62$632,890.0010,802View SEC Filing Icon  
2/13/2020Sell2,000$82.02$164,040.003,302View SEC Filing Icon  
1/15/2020Sell5,000$79.55$397,750.006,302View SEC Filing Icon  
12/12/2019Sell5,000$71.50$357,500.006,302View SEC Filing Icon  
11/21/2019Sell8,000$78.65$629,200.009,302View SEC Filing Icon  
11/19/2019Sell10,000$77.99$779,900.0011,302View SEC Filing Icon  
11/12/2019Sell10,000$70.97$709,700.0011,302View SEC Filing Icon  
10/22/2019Sell10,000$71.32$713,200.00
9/24/2019Sell10,000$73.69$736,900.00
9/17/2019Sell10,000$75.38$753,800.00
9/12/2019Sell10,000$76.36$763,600.00
See Full Table

Stanley J. Meresman Buying and Selling Activity at Guardant Health

This chart shows Stanley J Meresman's buying and selling at Guardant Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Guardant Health Company Overview

Guardant Health logo
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
Read More

Today's Range

Now: $17.35
Low: $16.78
High: $17.52

50 Day Range

MA: $18.84
Low: $16.07
High: $22.83

2 Week Range

Now: $17.35
Low: $15.81
High: $41.06

Volume

697,962 shs

Average Volume

1,880,424 shs

Market Capitalization

$2.11 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.87